BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 745402)

  • 21. Steroidal inhibitors of prostatic 5alpha-reductase: structure-activity relationships.
    Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
    J Steroid Biochem; 1978 Nov; 9(11):1043-7. PubMed ID: 745402
    [No Abstract]   [Full Text] [Related]  

  • 22. 5alpha-reductase activity in the prostate.
    Steers WD
    Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of 5α-reductase inhibitors in benign prostatic diseases.
    Azzouni F; Mohler J
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):222-30. PubMed ID: 22333687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS; Imperato-McGinley JL
    Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.